|CytomX Therapeutics Inc -- USA Stock|| |
USD 21 0.44 2.14%
Founder and Member of Scientific Advisory BoardWe currently do not have informatin regarding Prof Daugherty. This executive tanure with CytomX Therapeutics Inc is not currenlty determined.
The company has return on total asset (ROA)
of (14.12) %
which means that it has lost $14.12 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE)
of (81.04) %
meaning that it created substantial loss on money invested by shareholders.
CytomX Therapeutics, Inc. operates as an oncologyfocused biopharmaceutical company in the United States. CytomX Therapeutics Inc (CTMX) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 63 people. CytomX Therapeutics is listed under Pharmaceutical Products category by Fama And French industry classification.